Federal Register
Notices > Importers Notice of Application 2009
> Noramco, Inc.
FR Doc E9-16520[Federal Register: July 13, 2009 (Volume 74, Number 132)]
[Notices] [Page 33475-33476] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13jy09-109]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Application
Pursuant to 21
U.S.C. 958(i), the Attorney General shall, prior to issuing a registration
under this Section to a bulk manufacturer of a controlled substance in schedule
I or II, and prior to issuing a regulation under 21
U.S.C. 952(a)(2) authorizing the importation of such a substance, provide
manufacturers holding registrations for the bulk manufacture of the substance an
opportunity for a hearing.
Therefore, in accordance with Title 21, Code of Federal Regulations (CFR), 1301.34(a),
this is notice that on June 16, 2009, Noramco, Inc., Division of Ortho-McNeil,
Inc., 500 Swedes
[[Page 33476]]
Landing Road, Wilmington, Delaware 19801, made application by letter to the
Drug Enforcement Administration (DEA) to be registered as an importer of
Thebaine (9333), a basic class of controlled substance listed in schedule II.
The company plans to import a Thebaine derivative for the bulk manufacture of
controlled substances for their customers. The company will also import
analytical reference standards for distribution to their customers for research
purposes.
Any bulk manufacturer who is presently, or is applying to be, registered with
DEA to manufacture such basic class of controlled substance may file comments or
objections to the issuance of the proposed registration and may, at the same
time, file a written request for a hearing on such application pursuant to 21
CFR 1301.43 and in such form as prescribed by 21
CFR 1316.47.
Any such comments or objections being should be addressed, in quintuplicate,
to the Drug Enforcement Administration, Office of Diversion Control, Federal
Register Representative (ODL), 8701 Morrissette Drive, Springfield, VA 22152;
and must be filed no later than August 12, 2009.
This procedure is to be conducted simultaneously with, and independent of,
the procedures described in 21 CFR 1301.34(b), (c), (d), (e), and (f). As noted
in a previous notice published in the Federal Register on September 23, 1975, 40
FR 43745-46), all applicants for registration to import a basic class of any
controlled substances in schedule I or II are, and will continue to be, required
to demonstrate to the Deputy Assistant Administrator, Office of Diversion
Control, Drug Enforcement Administration, that the requirements for such
registration pursuant to 21
U.S.C. 958(a); 21
U.S.C. 823(a); and 21
CFR 1301.34(b), (c), (d), (e), and (f) are satisfied.
Dated: July 1, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-16520 Filed 7-10-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|